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INTRODUCTION
Inflammation is a natural response to injury or infection, which promotes tissue survival,
remodeling, and repair, as well as adaptation to stress and restoration of the homeostatic state (1).
In the acute phase of an inflammatory response, which could persist for a few days, inflammatory
factors such as cytokines/chemokines, immune-related effectors, acute phase proteins, and reactive
oxygen and nitrogen species are released, thereby triggering coordinated biological events (1).
However, a prolonged inflammatory response, also known as chronic low-grade inflammation
(1), may contribute to the pathogenesis of several cardiovascular and metabolic diseases (e.g.,
atherosclerosis, diabetes, and cancer) (2, 3) as well as to the development of neuropsychiatric
disorders and cognitive dysfunctions (4).
Cognition involves a set of mental processes that shape perception, memory, intellect, and
action, including executive functions (e.g., cognitive inhibition, cognitive flexibility, and working
memory), and other cognitive domains (e.g., verbal fluency and comprehension) (5). Although it
has been suggested that the immune system might modulate brain functioning, how inflammatory
factors could influence cognition is poorly understood. Here, we provide context and three open
questions that need to be answered to move the field forward.
Is Low-Grade Systemic Inflammation Associated With Cognition
in Children and Adolescents?
The current understanding of the association between systemic inflammation, which takes place
outside the central nervous system, and cognition has been mainly focused on the two endpoints
of the human life span as well as on psychiatric patients. In extremely preterm infants, incremented
levels of inflammatory proteins (e.g., C-reactive protein) have been related to impaired cognitive
function later in life (6, 7). Interestingly, prenatal inflammation, measured by interleukin-6, has
also been shown to have an impact on postnatal cognitive outcomes (8). In older adults, there is a
link between incremented levels of proinflammatory cytokines (e.g., interleukin-6, interleukin-1β,
and tumor necrosis factor-α) and neurodegenerative disorders, such as Alzheimer’s disease and
other dementias (9). In psychiatric patients, a growing body of evidence has shown that high
levels of proinflammatory cytokines and C-reactive protein are associated with altered cognition
in individuals with neuropsychiatric disorders, such as schizophrenia, bipolar disorder, and major
depressive disorders (10). Additionally, prior literature has pointed out that a state of chronic
low-grade systemic inflammation could also negatively influence cognition in healthy midlife
adults (11).
In contrast to this prior evidence, the association between inflammation and cognition, both
assessed during childhood and adolescence (4–18 years), is poorly understood since only six studies
have been conducted in this age group, showing inconclusive results (12–17). Concurring with
research in other age range populations, four studies have shown that elevated levels of circulating
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inflammatory factors in children and adolescents are associated
with impaired cognitive processes (12–14, 16). Conversely, two
studies reported null associations between these parameters (15,
17). This previous research focused on only some immune-
related effectors, cytokines, and C-reactive protein. With regard
to cognition, studies have mainly investigated memory (12, 15–
17) and a global measure of executive function (12, 14–16),
with only a few studies examining other cognitive domains,
such as cognitive inhibition (16, 17), cognitive flexibility (17),
or attention (14). The paucity of studies and the methodological
differences among them (e.g., selected signaling proteins and
cognitive-related outcomes, and study design) prevent drawing
firm conclusions and make necessary additional research on this
interesting and promising area.
During childhood and adolescence, brain regions are
continuously developing (18), which shapes the cognitive
domains. Indeed, these periods of life provide a developmental
window with a great opportunity to experience structural and
functional organization of the brain influenced by exogenous
and endogenous factors (19), for example, inflammation.
Therefore, future studies analyzing the impact of a wide range
of inflammatory factors on the whole range of cognitive
outcomes in children and adolescents are needed to advance our
understanding of this Research Topic.
How Could Inflammation Influence
Complex Higher-Order Neurological
Functions?
Inflammatory factors could influence cognition through two
different routes. Firstly, systemic inflammatory proteins can enter
the brain by crossing the blood–brain barrier via active transport
mechanisms or via vagal nerve stimulation (20). Secondly,
within the brain, inflammatory factors can be expressed
by astroglia, microglia, neurons, and endothelial cells as a
consequence of brain injury, trauma, or intracerebral infections
(21). In animal models, both systemic and central inflammation
may alter cognition through its effects on synaptic plasticity,
neurotransmission, and dendritic branching (22). In humans,
clinical research has suggested that systemic inflammatory agents
may play a substantial role in neurodevelopmental processes,
such as synaptic plasticity, neurogenesis, and neuromodulation
(21). Therefore, we speculate that inflammation alters these
brain functions, which ultimately leads to alterations in cognitive
functioning. The impact of inflammation on cognition could
be indirectly related to several cardiometabolic disorders
(e.g., obesity, type 2 diabetes, and hypertension), since the
pathogenesis of these disorders is closely linked to chronic
low-grade systemic inflammation (2, 3). However, the exact
molecular and cellular pathways by which inflammatory factors
may influence cognition remain to be elucidated. It is likely
that inflammatory agents exert unique effects in different
cortical regions and may have specific consequences on the
brain regions depending on the state of brain development
(23). Previous studies in humans, which included brain
imaging data, have suggested that peripheral proinflammatory
cytokines, such as interleukin-6, interleukin-1β, and tumor
necrosis factor-α, are associated with changes in functional
connectivity as well as in cortical thickness and surface area
in specific regions of the brain (23, 24). In this sense,
further longitudinal studies including brain imaging data,
which could detect brain function and structural adaptations,
may contribute to a better understanding of the effect of
inflammation on cognition over a period of time. In addition,
further studies could also analyze brain functions as mediator
mechanisms involved in the association between inflammation
and cognition.
How Could Inflammation Be Modulated to
Improve Cognition?
Therapeutic or prophylactic immunomodulation is a strategy
that activates the non-specific immune system to counteract
inflammation (25). Alternatively, prior evidence has suggested
that lifestyle behaviors, such as diet, physical activity, or
sleep, could act as preventive strategies influencing the
inflammatory levels, since associations between these behaviors
and inflammation have been reported in children and adolescents
(26, 27). For instance, physical activity affects inflammatory
mediators by the reduction of visceral fat mass, improvement of
endothelial function and insulin sensitivity, and elevation of anti-
inflammatory cytokines levels and other muscle contraction-
derived proteins (28).
Considering that childhood and adolescence are crucial
periods of life in terms of establishing healthy lifestyle behaviors
and acquisition of cognitive skills, the investigation of the
influence of these modifiable behaviors on inflammation
and cognitive functioning is of paramount importance.
Therefore, from a public health perspective, further prospective
cohort studies and non-pharmacological randomized lifestyle
interventions focusing on inflammation as a primary outcome
could help to predict the direction of causality and to understand
its role in cognition in youths. In addition, since the mechanisms
underlying these associations have not been clearly identified,
we believe that inflammatory-mediated pathways in relation
to cognition should be considered as a new and exciting
Research Topic.
CONCLUSION
Since high levels of inflammatory factors during childhood
and adolescence, considered important periods of life in terms
of brain development, seem to track into adulthood (29),
the promotion of health is particularly needed. Thus, further
research is warranted to not only facilitate our understanding
of neural-immune communication pathways and cytokine-
mediated pathophysiological processes but also to design efficient
non-pharmacological lifestyle intervention programs to tackle
inflammation-related diseases. These lifestyle interventions may
be cost-effective, overcoming the benefits of pharmacological
approaches (e.g., anti-inflammatory drugs, immunomodulators,
or nutraceuticals), since they may exert multi-systemic positive
effects on health with little contraindications and at a lower
cost. Moreover, lifestyle interventions could be used not only as
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treatment strategies but also as primary prevention strategies.
Future studies should consider participants’ maturational status
to account for individual developmental features. In addition,
studies should include sample sizes large enough to provide
significant statistical power as well as guarantee participants’
compliance. Specifically, lifestyle interventions focused on
physical activity should precisely define its dose in terms of
intensity, type, and duration in order to facilitate comparisons
among studies. With regard to diet, interventions should focus
not only on dietary patterns but also on the intake of specific
foods, nutrients, and non-nutrient food components. Lastly,
sleep interventions aimed at modulating inflammation through
the improvement of sleep patterns should also be considered.
Based on previous scientific literature, low-grade systemic
inflammatory proteins could be identified as critical factors for
cognitive functioning during youth. We believe that the scientific
community should be aware of the gap highlighted in this
manuscript in order to take action and expand the knowledge on
inflammation and cognition in the young population.
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